RT @GRTDnews: The UK’s new MHRN strengthens global prevention, preparedness & response to outbreaks & multi-hazard crises through rapid exp…

Le Royaume-Uni vient de lancer un nouveau réseau de recherche multi-risques, réunissant des experts afin de renforcer la prévention, la preparation et la réponse aux épidémies, y compris l’Ebola en RDC. gov.uk/government/news/uk-la…

La semaine dernière en RDC, @JennyChapman a vu le travail accompli par des partenaires pour contenir l’épidémie d’Ebola et protéger les communautés. L’ampleur du défi ne doit pas être sous-estimée. Le Royaume-Uni continuera de soutenir une riposte menée par les pays africains.

RT @GRTDnews: 📢 Call for Applications: Eleven Senior Research Fellowships Hosted by FCDO in London or East Kilbride, these two-year placem…

The only way we are going to tackle the global challenges of today is through partnerships. We must draw on the strengths that everyone has to offer. That is how we build a better future. Read my speech at the Global Partnerships Conference here ⤵️ gov.uk/government/speeches/b…

Watch the Global Partnerships Conference livestream on YouTube here ⤵️ youtube.com/live/T7cC_ke52kY

The world has changed. But our values, ambition and determination to build a safer, fairer and more prosperous world, remains stronger than ever. To achieve this ambition, the way we work together must change too. independent.co.uk/news/uk/ho…

Just over one month left to apply for infectious disease clinical trial funding. ⏰ We’re supporting transdisciplinary teams led from Africa, South Asia or South-East Asia to run randomised controlled trials that optimise licensed vaccines and therapeutics for infectious diseases. The goal: generate evidence that can inform changes to policy, practice or guidelines – and improve prevention and treatment in the communities most affected. • Level: £1,000,000 – £8,000,000 per award. • Duration: 3 – 5 years • Deadline: 2 June 2026 Delivered in partnership with NIHR: wellc.me/4rw0myj

British-backed science has helped build today’s antimalarial toolbox. Sustained support can get us closer to #ZeroMalaria. UK Parliamentarians explored tools behind progress against #malaria and innovations that can define what’s next at @malarianomoreuk’s #WorldMalariaDay event

Today, the UK set out new innovative development reforms – ensuring every pound delivers for the UK taxpayer and the people we support.

Preliminary Market Engagement Notice: Jobs and Inclusive Growth Centre of Expertise - Technical Assistance Facility. Thursday 26th March 26. Access bit.ly/4btNhj1 or the QR code below for more information on this opportunity. #FCDOGovUK #UKAid

@DHSCgovuk (through NIHR), @FCDOGovUK and @wellcometrust are funding clinical trials led by researchers in Africa, South and South-East Asia! 🔷 Focus: high-burden infectious diseases. 🔷Awards £1–8m. Find out more ➡️ nihr.ac.uk/news/new-funding-… #GlobalHealth #ClinicalTrials

New funding for infectious disease clinical trials! 📣  We’re funding randomised controlled trials to optimise existing vaccines and therapeutics for infectious diseases. This research must be led by those closest to the challenge. The lead applicant must be based in a low- or middle-income country in Africa, South Asia, or South-East Asia. Trials should focus on one of the following disease areas: • mycobacterial infections (tuberculosis, leprosy or infections with non-tuberculous mycobacteria) • bacterial infections (sexually transmitted infections, lower respiratory tract infections or bloodstream infections) • invasive fungal infections • dengue, leishmaniasis or schistosomiasis If you have an innovative idea for a randomised controlled trial proposal, but need to build your team, develop your clinical trial protocol or generate pilot data, you can apply to our Infectious Disease Clinical Trial Development Award. Delivered in partnership with @NIHRresearch and @FCDOResearch Learn more about eligibility and how to apply ⤵️ wellcome.org/research-fundin…

🤝 This achievement reflects over a decade of collaboration and innovation across the global health community. We thank our partners, donors, staff & everyone who was involved in making the dream of a single-dose, oral treatment for sleeping sickness come true.

🚀 Huge news for people living with #sleepingsickness! Acoziborole, a one-day, single-dose oral treatment developed with @sanofi, has received a positive opinion from @EMA_News for the treatment of the most common form of sleeping sickness. 👉bit.ly/4rDnDil #beatNTDs

At the @OfficialINDIAai Impact Summit, we are joining partners investing in evidence to guide governments, donors and NGOs in funding and scaling up AI where it has the greatest potential to maximise social good. AI for Social Good. @JPAL @FCDOResearch @GoogleDeepMind

Long-term investment in #malaria innovation pays off in measurable ways. A @LancetGH study (2000-2023) finds investments in MMV deliver 13× their value in health benefits. See why PDPs like MMV offer a proven model for global health investment: bit.ly/4aC2yhh

🌍 How can we better include learners with disabilities in mainstream education? Our dialogue builds on the 2025 @GDS_Disability to share evidence and develop a roadmap for turning research into action. 🤝 @IDA_CRPD_Forum I @LSHTM I @FCDOGovUK 🔗 wiltonpark.org.uk/event/disa…

📢 Funding opportunity! Raising Adaptation Impact and Ambition (RAIA) is inviting funding proposals to support research on the economics of climate change adaptation in Africa. Call info session:buff.ly/nM3DGJX ✍️Apply:buff.ly/1FnVHvn @UNEP @FCDOResearch

Happy @UN International Day of Women and Girls in Science. Celebrating the curiosity, talent and leadership of women across science, engineering and technology. #WomenInScience #GirlsInScience #11February #CelebratingScienceAdvice #WomenInSTEM